A Duration-Dependent Interaction Between High-Intensity Light and Unrestricted Vision in the Drive for Myopia Control.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
entrez:
23
3
2023
pubmed:
24
3
2023
medline:
28
3
2023
Statut:
ppublish
Résumé
To evaluate the duration-dependent and synergetic impact of high-intensity light (HL) and unrestricted vision (UnV) on lens-induced myopia (LIM) development in chickens. Myopia was induced in one eye in chicks (10 groups, n = 126) from day 1 posthatching (D1) until day 8 (D8) using -10 diopter (D) lenses. Fellow eyes remained uncovered as controls. Nine groups were exposed daily to 2, 4, or 6 hours of HL (15,000 lux), UnV (removal of -10 D lens), or both (HL + UnV). One group served as the LIM group without any interventions. Ocular axial length (AL), refractive error, and choroidal thickness were measured on D1, D4, and D8. Outcome measures are expressed as interocular difference (IOD = experimental eye - control eye) ± SEM. By D8, LIM increased AL (0.36 ± 0.04 mm), myopic refraction (-9.02 ± 0.37 D), and choroidal thinning (-90.27 ± 16.44 µm) in the LIM group (all, P < 0.001). Compared to the LIM group, exposure to 2, 4, or 6 hours of HL, UnV, or HL + UnV reduced myopic refraction in a duration-dependent manner, with UnV being more effective than HL (P < 0.05). Only 6 hours of HL + UnV (not 2 or 4 hours) prevented LIM and was more effective than UnV (P = 0.004) or HL (P < 0.001) in reducing myopic refraction and more effective than HL (P < 0.001) in reducing axial elongation. Daily exposure to 2, 4, or 6 hours of HL, UnV, or HL + UnV reduced lens-induced myopic refraction in a duration-dependent manner in chickens. Only 6 hours of HL + UnV completely stopped LIM development. The synergetic effect of HL and UnV is dependent on the duration of the interventions.
Identifiants
pubmed: 36951855
pii: 2785471
doi: 10.1167/iovs.64.3.31
pmc: PMC10050902
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
31Références
Exp Eye Res. 2011 Nov;93(5):782-5
pubmed: 21872586
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):16
pubmed: 35133400
Neurochem Int. 2006 Jan;48(1):17-23
pubmed: 16188347
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5247-53
pubmed: 20445123
Brain Res. 1987 Oct 20;424(1):199-203
pubmed: 3690300
Mol Vis. 2010 Apr 13;16:639-49
pubmed: 20405027
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7423-32
pubmed: 25324283
Sci Rep. 2021 Apr 7;11(1):7586
pubmed: 33828194
Am J Ophthalmol. 2014 Nov;158(5):1079-85
pubmed: 25072831
Invest Ophthalmol Vis Sci. 2013 Apr 26;54(4):2959-69
pubmed: 23557736
Exp Eye Res. 2013 Sep;114:77-88
pubmed: 23290590
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4319-4327
pubmed: 31622468
JAMA. 2015 Sep 15;314(11):1142-8
pubmed: 26372583
PLoS One. 2014 Oct 31;9(10):e110906
pubmed: 25360635
Ophthalmic Physiol Opt. 2013 May;33(3):227-44
pubmed: 23662957
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2242-52
pubmed: 15980207
Sci Rep. 2019 Aug 7;9(1):11459
pubmed: 31391523
Exp Eye Res. 2002 May;74(5):561-70
pubmed: 12076077
Vision Res. 2006 Oct;46(22):3935-40
pubmed: 16806391
Exp Eye Res. 2007 May;84(5):951-9
pubmed: 17395180
Invest Ophthalmol Vis Sci. 2014 Dec 09;56(1):299-309
pubmed: 25491298
Int J Ophthalmol. 2014 Apr 18;7(2):245-50
pubmed: 24790865
Optom Vis Sci. 1999 May;76(5):308-15
pubmed: 10375247
Exp Eye Res. 2017 Aug;161:132-142
pubmed: 28596085
Appl Opt. 1987 Apr 15;26(8):1505-9
pubmed: 20454351
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5348-54
pubmed: 19516016
Ther Adv Ophthalmol. 2021 Dec 19;13:25158414211059246
pubmed: 34988370
Vision Res. 1986;26(12):1977-93
pubmed: 3617538
Ophthalmol Ther. 2022 Jun;11(3):939-957
pubmed: 35275382
Prog Retin Eye Res. 2018 Jan;62:134-149
pubmed: 28951126
BMC Ophthalmol. 2015 Jul 09;15:73
pubmed: 26152123
Exp Eye Res. 2000 Apr;70(4):519-27
pubmed: 10866000
Prog Retin Eye Res. 2017 Nov;61:60-71
pubmed: 28602573
Sci Rep. 2022 Dec 15;12(1):21704
pubmed: 36522540
Eye Contact Lens. 2019 Sep;45(5):279-285
pubmed: 30932926
Sci Rep. 2020 Aug 6;10(1):13242
pubmed: 32764736
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4779-89
pubmed: 27618415
Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1593-601
pubmed: 22323488
Vision Res. 1997 Aug;37(15):2011-21
pubmed: 9327048
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):421-8
pubmed: 22169102
Prog Retin Eye Res. 2012 Nov;31(6):622-60
pubmed: 22772022
Exp Eye Res. 1999 Jul;69(1):9-20
pubmed: 10375445
Curr Eye Res. 2015 Sep;40(9):962-7
pubmed: 25310574
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):42
pubmed: 32986814
Eur J Neurosci. 2005 Apr;21(8):2199-208
pubmed: 15869516
Ophthalmology. 2018 Aug;125(8):1239-1250
pubmed: 29371008
Invest Ophthalmol Vis Sci. 2014 Feb 04;55(2):752-8
pubmed: 24408976
Nat Rev Dis Primers. 2020 Dec 17;6(1):99
pubmed: 33328468
Optom Vis Sci. 2019 Jun;96(6):463-465
pubmed: 31116165
Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8056-62
pubmed: 21911586
Optom Vis Sci. 2004 Feb;81(2):137-47
pubmed: 15127933
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2856-65
pubmed: 22491403
Ophthalmic Physiol Opt. 2013 May;33(3):368-72
pubmed: 23662968
Vision Res. 1996 Apr;36(7):1023-36
pubmed: 8736261
Exp Eye Res. 1999 Jan;68(1):105-15
pubmed: 9986748
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):3
pubmed: 33909035
Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):28
pubmed: 33502461
Exp Eye Res. 2017 Jan;154:104-115
pubmed: 27845062
Ophthalmic Physiol Opt. 2013 May;33(3):355-61
pubmed: 23662966
Exp Eye Res. 2012 Oct;103:33-40
pubmed: 22960317
Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):4
pubmed: 33016984